Group One Trading’s VolitionRx Ltd VNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,100
Closed -$15.2K 8256
2023
Q3
$15.2K Hold
1,100
﹤0.01% 6094
2023
Q2
$30.6K Buy
1,100
+585
+114% +$19.2K ﹤0.01% 5666
2023
Q1
$19.7K Buy
+515
New +$21.6K ﹤0.01% 5520
2022
Q4
Sell
-50
Closed -$14K 8155
2022
Q3
$14K Hold
50
﹤0.01% 6307
2022
Q2
$2K Buy
50
+35
+233% +$1.76K ﹤0.01% 7449
2022
Q1
$1K Hold
15
﹤0.01% 7887
2021
Q4
$1K Buy
+15
New +$1.02K ﹤0.01% 8034
2021
Q3
Sell
-110
Closed -$7K 8845
2021
Q2
$7K Buy
110
+80
+267% +$5.41K ﹤0.01% 7673
2021
Q1
$2K Buy
+30
New +$2.57K ﹤0.01% 7410
2020
Q4
Sell
-100
Closed -$6K 7046
2020
Q3
$6K Hold
100
﹤0.01% 5596
2020
Q2
$8K Buy
+100
New +$7.22K ﹤0.01% 5233

Other funds holding VNRX

Group One Trading's VNRX Position: Q1 2026 in Review

Group One Trading held its VolitionRx Ltd (VNRX) position steady in Q1 2026 at 2,500 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6368.

Group One Trading first reported a position in VNRX in Q2 2020 and has held it in 10 quarters since. The position peaked at $12.8K in Q4 2025. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Group One Trading held 2,500 shares of VolitionRx Ltd worth $10.1K as of Q1 2026.
  • Group One Trading left its VolitionRx Ltd share count unchanged in Q1 2026.
  • VolitionRx Ltd made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6368 holding.
  • Group One Trading first reported a position in VolitionRx Ltd in Q2 2020 and has held it in 10 quarters since.
  • Group One Trading's VolitionRx Ltd position peaked at $12.8K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.